From: Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
General study details | Study ID number, lead author, title, journal, year of publication, type of publication, information source |
Study characteristics | Study design, study duration, pilot/feasibility study (y/n), number of study arms, covariates (definition and measurement methods) |
Participants | 1. Total number, setting, inclusion and exclusion criteria 2. Participant characteristics at baseline: for each study, average age (years, mean and standard deviation [SD]), sex (%), country, and time since diagnosis (or time since treatment, if treatment was completed) |
Interventions/exposures and comparators | 1. Total number of intervention/exposure and comparison groups and number of participants in each group 2. For each intervention/exposure and comparison group: intervention/exposure/comparison, duration of intervention/exposure, who and how assessed, and results of assessment |
Outcomes | The approach used in the study for assessing pain intensity including categorical scales (e.g., mild, moderate, severe), numerical rating scales (NRS), visual analog scales (VAS), and well-validated verbal scales (eg, the Descriptor Differential Scale). |
Results | For each quantitative outcome: sample size, number of missing participants, reasons for loss to follow up, summary data for each group (2 × 2 table for dichotomous data, means and SDs for continuous data), estimate of effect for the difference between groups (or change in baseline and final scores for single-arm studies), confidence intervals, and p value |